Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 5Sarcopenia 3Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Neoplasms 2Wound Infection 1Weight Loss 1Surgical Wound Infection 1Smoldering Multiple Myeloma 1Skin Neoplasms 1Psoriasis 1Precancerous Conditions 1Postoperative Complications 1Phagocyte Bactericidal Dysfunction 1Pain 1Osteoarthritis 1Olfaction Disorders 1Obesity 1Neuroma, Acoustic 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Mandibular Neoplasms 1Malnutrition 1Fatigue 1Dermatitis, Contact 1Colorectal Neoplasms 1Cancer Cachexia 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthralgia 1

Interventions

Omacor 1Nutrition Assessment 1Eicosapentaenoic Acid 1Docosahexaenoic Acids 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Cancer Cachexia × Docosahexaenoic Acids × Clear all
NCT00815685 2017-03-23

A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
36 enrolled 7 charts

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡